EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Upadacitinib as rescue therapy for corticosteroid failure acute severe ulcerative colitis: an Asian experience from Taiwan

Chen-Shuan Chung, Wei-Wei Lee, Puo-Hsien Le

International Journal of Colorectal Disease · 11.02.2025 · 40 (1)

DOI: 10.1007/s00384-025-04825-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Colorectal Disease, online erschienen am 11.02.2025. Verfasst von Chen-Shuan Chung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Adrenal Cortex Hormones, Heterocyclic Compounds, 3-Ring, Asian People. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Acute severe ulcerative colitis (ASUC) is a medical emergent condition, and approximately one-third of patients with ASUC do not respond to corticosteroid. Whether small molecule drugs are efficient and safe for salvage therapy of ASUC is not well-understood.

Methods

Consecutive patients with ASUC who failed responding to first-line corticosteroid were retrospectively enrolled. Clinical, laboratory, endoscopic, and pathological data were analyzed.

Results

Five Asian male patients (median age of 38.9 years old) with ASUC who received salvage therapy with upadacitinib were enrolled. The mean (± standard deviation) disease duration was 3.44 (± 3.30, 0.53 ~ 7.88) years. Baseline Montreal disease extent, C-reactive protein, and erythrocyte sedimentation rate were four (80%) E3 and one (20%) E2 disease, 40.54 (± 74.26) mg/dl, and 24.50 (± 19.09) mm/h, respectively. Daily upadacitinib 45 mg was prescribed for 56 days in all patients. Clinical response, clinical remission, corticosteroid-free remission, and endoscopic improvement at weeks 8 and 12 were achieved in five (100%) and five (100%), four (80%) and five (100%), four (80%) and five (100%), and four (80%) and five (100%) patients, respectively. One (20%) patient achieved histo-endoscopic remission at week 24. None of them had re-hospitalization or colectomy during the follow-up period but one patient developed penile simplex-1 infection which resolved after topical antiviral ointment without upadacitinib discontinuation.

Conclusions

Upadacitinib is an efficient salvage therapy for patients with ASUC. Further investigations are essential to assess long-term durability, safety profile, and viability as a bridging regimen in the treatment of ASUC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeAdrenal Cortex HormonesHeterocyclic Compounds, 3-RingAsian PeopleHumansMaleAdultTaiwanMiddle AgedTreatment FailureAcute DiseaseSalvage TherapyTreatment OutcomeSeverity of Illness Index

Stichwörter der Autor:innen

Acute severe ulcerative colitisSalvage therapySmall molecule drugsUpadacitinib

Substanzen

Adrenal Cortex HormonesupadacitinibHeterocyclic Compounds, 3-Ring

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
  • College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
  • Taiwan Association for the Study of Intestinal Diseases (TASID), Taoyuan, Taiwan.
  • Taiwan Association for the Study of Intestinal Diseases (TASID), Taoyuan, Taiwan. puohsien@gmail.com.
  • Department of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan. puohsien@gmail.com.
  • Inflammatory Bowel Disease Center, Linkou Chang Gung Memorial Hospital, 5, Fu-Hsin Street, Guei-Shan District, Taoyuan, 33305, Taiwan. puohsien@gmail.com.

Zitieren

APA

Chung, C. S., Lee, W. W., & Le, P. H. (2025). Upadacitinib as rescue therapy for corticosteroid failure acute severe ulcerative colitis: an Asian experience from Taiwan. International Journal of Colorectal Disease, 40(1). https://doi.org/10.1007/s00384-025-04825-w

Vancouver

Chung CS, Lee WW, Le PH. Upadacitinib as rescue therapy for corticosteroid failure acute severe ulcerative colitis: an Asian experience from Taiwan. International Journal of Colorectal Disease. 2025;40(1). doi:10.1007/s00384-025-04825-w

BibTeX
@article{Chung2025,
  author = {Chung, Chen-Shuan and Lee, Wei-Wei and Le, Puo-Hsien},
  title = {Upadacitinib as rescue therapy for corticosteroid failure acute severe ulcerative colitis: an Asian experience from Taiwan},
  journal = {International Journal of Colorectal Disease},
  year = {2025},
  volume = {40},
  number = {1},
  doi = {10.1007/s00384-025-04825-w}
}
Kostenlos starten →